El Salvador Achieves Historic WHO Validation for Eliminating Trachoma as a Public Health Problem

El Salvador has achieved a monumental public health milestone, receiving official validation from the World Health Organization (WHO) for eliminating trachoma as a public health problem. This recognition marks El Salvador as the first country in Central America and only the second in the entire Americas region to eradicate the world’s leading infectious cause of blindness, signaling a profound victory for public health and a beacon of hope in the global fight against neglected tropical diseases. The validation follows a rigorous, multi-year process of comprehensive assessments and sustained programmatic efforts, confirming the absence of active transmission and the robust capacity of the nation’s health system to prevent its re-emergence.

The Scourge of Trachoma: A Global Health Challenge

Trachoma, caused by the bacterium Chlamydia trachomatis, is a devastating infectious disease that disproportionately affects impoverished communities with limited access to clean water, adequate sanitation, and proper hygiene. Its insidious progression begins with repeated bacterial infections of the eye, often spread through contact with eye and nasal discharge from infected individuals, and exacerbated by poor environmental conditions and the presence of flies. Over time, these recurrent infections lead to scarring of the inner eyelid, a condition known as conjunctival scarring. This scarring can cause the eyelashes to turn inward, painfully scraping against the cornea with every blink—a condition called trachomatous trichiasis (TT). Left untreated, TT inevitably leads to irreversible corneal opacities and ultimately, permanent blindness.

Globally, trachoma has historically been a significant cause of preventable blindness, affecting millions of people, particularly women and children, in some of the most vulnerable regions. The disease not only imposes immense personal suffering and loss of sight but also inflicts a heavy socio-economic burden on individuals, families, and national economies. Blindness due to trachoma robs individuals of their independence, reduces productivity, limits educational and employment opportunities, and perpetuates cycles of poverty within affected communities. The global health community, recognizing this profound impact, has long prioritized the elimination of trachoma as a critical step towards achieving health equity and sustainable development.

A Decades-Long Global Effort: The SAFE Strategy

The global commitment to eliminating trachoma gained significant momentum in 1996 with the launch of the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020). This alliance brought together a diverse network of governments, non-governmental organizations, academic institutions, and partners dedicated to eradicating the disease. The cornerstone of this global strategy is the SAFE approach:

• Surgery for trachomatous trichiasis (TT) to prevent irreversible blindness.
• Antibiotics, primarily mass drug administration (MDA) with azithromycin, to treat active infection.
• Facial cleanliness, promoted through health education and improved access to water.
• Environmental improvements, focusing on better access to water, sanitation, and hygiene (WASH) facilities to reduce transmission.

This comprehensive, multi-pronged strategy addresses both the immediate clinical manifestations of the disease and its underlying social and environmental determinants. The success of SAFE relies heavily on strong political commitment, community engagement, and integrated health services delivery, principles that El Salvador meticulously applied throughout its elimination journey. While GET2020 initially aimed for elimination by 2020, the target has since been extended to 2030, reflecting the complexities and challenges of eradicating a disease deeply intertwined with poverty.

El Salvador’s Meticulous Journey to Validation: A Timeline of Dedication

El Salvador’s path to trachoma elimination is a testament to sustained national effort, strategic partnerships, and a resolute focus on reaching the most vulnerable populations. While previously categorized among countries where the disease was suspected or endemic, the nation embarked on a comprehensive, multi-year program to assess and combat trachoma. The Minister of Health, Francisco Alabi, highlighted the remarkable speed of their achievement, stating, "We are proud to have reached this achievement in just three years, positioning the country in the region and improving the visual health of our population." This accelerated progress underscores a period of intensified national efforts, program implementation, and assessment activities.

The rigorous validation process, conducted under the stringent guidelines of the WHO, involved several critical phases:

1. Initial Assessment and Program Design: Early identification of high-risk communities based on environmental and social factors, followed by the design of targeted interventions.
2. Implementation of SAFE Strategy: Deploying surgical services for trichiasis, distributing antibiotics, promoting facial cleanliness, and investing in WASH infrastructure in identified areas. This included strengthening primary health care services and integrating eye health services, such as visual acuity screening in adults, into routine care.
3. Surveillance and Data Collection: Establishing robust surveillance mechanisms to track disease prevalence, identify potential cases, and monitor the effectiveness of interventions.
4. Targeted Assessments (2023-2026): The culmination of these efforts involved focused epidemiological assessments in prioritized communities. These detailed investigations, which concluded prior to the validation, found no evidence of active transmission of trachoma. Crucially, no signs of the disease were detected in children aged 1-9 years, and no advanced cases of trichiasis capable of causing blindness were found in adults aged 15 years and above. These findings definitively confirmed that trachoma no longer constituted a public health problem in the country according to WHO criteria.

Throughout this process, El Salvador benefited significantly from a multisectoral approach, fostering collaboration among various government sectors, communities, and international partners. The Pan American Health Organization (PAHO) played a crucial supporting role through its Initiative for the Elimination of Trachoma in the Americas, working in close collaboration with the Government of Canada. This partnership not only facilitated the technical and financial support necessary for the elimination efforts but also created valuable opportunities to deliver integrated health services to the communities reached during the assessments, enhancing overall public health infrastructure.

Defining Elimination: The WHO Criteria

The WHO sets specific epidemiological criteria for validating the elimination of trachoma as a public health problem. These criteria ensure that the disease is no longer a significant threat and that a sustainable system is in place to prevent its re-emergence:

• Trachomatous Trichiasis (TT) Prevalence: A prevalence of TT "unknown to the health system" of less than 0.2% in individuals aged 15 years and older in each formerly endemic district. This means that virtually all advanced cases have either been treated or are identified and managed within the health system.
• Trachomatous Inflammation – Follicular (TF) Prevalence: A prevalence of trachomatous inflammation – follicular (TF) in children aged 1-9 years of less than 5% in each formerly endemic district. TF indicates active infection, and this low threshold confirms the interruption of transmission.
• Sustainable Surveillance and Management System: The existence of a robust system to identify and manage incident cases of TT, ensuring that any new cases are promptly detected and treated, and that the country can respond effectively to any potential re-emergence.

El Salvador successfully met all these stringent requirements, demonstrating not only the absence of the disease but also the enduring capacity of its national health system to sustain this achievement. This includes trained health personnel, integrated surveillance mechanisms, and the ability to detect and manage trichiasis cases effectively within the national health system.

Official Reactions and Global Implications

The validation of El Salvador’s achievement has been met with widespread commendation from global health leaders. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the nation’s success, stating, "I congratulate El Salvador on this remarkable achievement. It is a testament to the power of political commitment, strategic investment, and community engagement. El Salvador’s success is a vital step towards our global target of eliminating trachoma worldwide by 2030 and a clear signal that a healthier, more equitable future is within reach." His words underscore the critical elements that underpinned El Salvador’s victory and its broader significance for global health targets.

Dr. Jarbas Barbosa, Director of the Pan American Health Organization (PAHO), echoed this sentiment, emphasizing the equitable nature of the effort: "This validation reflects El Salvador’s commitment to reaching populations in the most vulnerable conditions and generating solid evidence to demonstrate that trachoma is not endemic in the country. It is the result of sustained efforts to reach communities, identify potential cases, and ensure no one was left behind." This highlights the core principle of universal health coverage and the imperative to address health inequities.

Minister of Health, Francisco Alabi, expressed national pride in this monumental achievement: "El Salvador has reached a major health milestone by achieving certification as a country free of trachoma, the result of sustained national efforts, with the support of the Pan American Health Organization and the Embassy of Canada." He emphasized the impact on the nation’s visual health and its enhanced standing in the region.

Broader Impact and Regional Leadership

El Salvador’s elimination of trachoma holds significant implications, extending far beyond its national borders. As the first country in Central America and the second in the Americas to achieve this milestone (Mexico being the first in the Americas), El Salvador establishes itself as a regional leader in public health. Its success provides a tangible blueprint and inspires other countries in the region still grappling with the disease, such as Brazil, Colombia, Guatemala, and Peru. Furthermore, it offers valuable lessons for countries where trachoma has been suspected, including the Plurinational State of Bolivia, Ecuador, Guyana, Panama, Paraguay, and the Bolivarian Republic of Venezuela, encouraging them to expand their epidemiological investigations.

This achievement also contributes significantly to PAHO’s ambitious Disease Elimination Initiative, which targets the elimination of more than 30 communicable diseases and related conditions in the Americas by 2030. Trachoma is one of several neglected tropical diseases (NTDs) that inflict devastating health, social, and economic consequences, primarily on impoverished communities in tropical regions. El Salvador’s success demonstrates that with concerted effort, political will, and international collaboration, these diseases can indeed be conquered.

Globally, El Salvador joins a distinguished group of 32 other countries validated by WHO for eliminating trachoma as a public health problem. This list includes nations like Algeria, Australia, Benin, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Libya, Malawi, Mali, Mauritania, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Tunisia, Vanuatu, and Viet Nam. This growing list underscores the progress being made towards the global 2030 target, reinforcing the feasibility of a world free from this preventable blindness.

Moreover, El Salvador now stands among 64 countries worldwide that have been recognized by WHO for eliminating at least one neglected tropical disease, with seven of these countries located in the Americas. This demonstrates a broader trend of strengthening health systems and increased focus on NTD control and elimination efforts globally, aligned with the roadmap for neglected tropical diseases 2021–2030.

Sustaining the Victory: Vigilance and Ongoing Commitment

While the validation marks a historic triumph, the fight is not entirely over. WHO recommends that countries achieving elimination maintain robust surveillance systems and ensure continued access to quality eye care services. This vigilance is crucial to prevent the re-emergence of the disease, especially in a world with increasing global travel and potential for reintroduction. El Salvador’s commitment to sustaining this achievement through trained health personnel, integrated surveillance, and continuous capacity for trichiasis management positions it well for long-term success.

El Salvador’s journey serves as a powerful illustration that public health challenges, no matter how entrenched, can be overcome through a combination of scientific strategy, dedicated resources, community partnership, and unwavering political will. It is a testament to the transformative power of health interventions and a reminder that a healthier, more equitable future is not just an aspiration but an achievable reality.